Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TOFACITINIB Cause Alanine aminotransferase increased? 440 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 440 reports of Alanine aminotransferase increased have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.3% of all adverse event reports for TOFACITINIB.

440
Reports of Alanine aminotransferase increased with TOFACITINIB
0.3%
of all TOFACITINIB reports
3
Deaths
128
Hospitalizations

How Dangerous Is Alanine aminotransferase increased From TOFACITINIB?

Of the 440 reports, 3 (0.7%) resulted in death, 128 (29.1%) required hospitalization, and 24 (5.5%) were considered life-threatening.

Is Alanine aminotransferase increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 440 reports have been filed with the FAERS database.

What Other Side Effects Does TOFACITINIB Cause?

Drug ineffective (30,382) Pain (21,659) Condition aggravated (16,925) Arthralgia (15,640) Fatigue (13,551) Rheumatoid arthritis (12,277) Off label use (11,736) Headache (11,061) Joint swelling (10,686) Malaise (9,040)

What Other Drugs Cause Alanine aminotransferase increased?

METHOTREXATE (2,440) RITUXIMAB (1,651) ADALIMUMAB (1,308) TOCILIZUMAB (1,163) ETANERCEPT (1,131) LEFLUNOMIDE (1,099) ACETAMINOPHEN (1,083) REMDESIVIR (1,047) FINGOLIMOD (1,020) INFLIXIMAB (981)

Which TOFACITINIB Alternatives Have Lower Alanine aminotransferase increased Risk?

TOFACITINIB vs TOFERSEN TOFACITINIB vs TOLNAFTATE TOFACITINIB vs TOLODODEKIN ALFA TOFACITINIB vs TOLTERODINE TOFACITINIB vs TOLVAPTAN

Related Pages

TOFACITINIB Full Profile All Alanine aminotransferase increased Reports All Drugs Causing Alanine aminotransferase increased TOFACITINIB Demographics